RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
USWGX
Price
$29.59
Change
-$1.24 (-4.02%)
Updated
Dec 18 closing price
Ad is loading...

RWIBX vs USWGX

Header iconRWIBX vs USWGX Comparison
Open Charts RWIBX vs USWGXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
Victory Sustainable World A
Price$29.59
Change-$1.24 (-4.02%)
VolumeN/A
CapitalizationN/A
RWIBX vs USWGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. USWGX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and USWGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. USWGX (1.44B). RWIBX pays higher dividends than USWGX: RWIBX (1.05) vs USWGX (0.72). RWIBX was incepted earlier than USWGX: RWIBX (23 years) vs USWGX (14 years). RWIBX is a more actively managed with annual turnover of: 27.00 vs. USWGX (23.00). RWIBX has a lower initial minimum investment than USWGX: RWIBX (250) vs USWGX (2500). USWGX annual gain was more profitable for investors over the last year : 18.05 vs. RWIBX (11.34). RWIBX return over 5 years is better than : 29.64 vs. USWGX (25.23).
RWIBXUSWGXRWIBX / USWGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years14 years-
Gain YTD9.78116.05561%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets121B1.44B8,391%
Annual Yield % from dividends1.050.72145%
Returns for 1 year11.3418.0563%
Returns for 3 years8.4116.2452%
Returns for 5 years29.6425.23117%
Returns for 10 years44.2215.62283%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics